Pemvidutide for obesity

A treatment and a condition, followed through the public trial records. Not medical advice. How a status is set

Phase 2 trial. Mid-stage trial in people. As of 19 Nov 2026, from 1 registered trial.

Why this status

  1. 15 May 2025: Trial started, NCT06987513
  2. 23 May 2025: Trial registered, NCT06987513

The trials

NCT06987513: RECLAIM STUDY: Phase 2 Study of the Efficacy and Safety of Pemvidutide in the Treatment of Alcohol Use Disorder (AUD) in Subjects With Obesity or Overweight

State
Completed
Phase
Phase 2
People
100 taking part
Started
15 May 2025
Primary completion
30 Jul 2026
Arms
Pemvidutide 2.4 mg
Results
None posted
  1. 15 May 2025: Trial started
  2. 23 May 2025: Trial registered
  3. 30 Jul 2026: Trial completed

How the status changed

  1. 19 Nov 2026: First set: Phase 2 trial

About the treatment

Kind of treatment: Drug.

Registries searched: ClinicalTrials.gov, through 17 Nov 2026.